ETNHX
Price
$34.51
Change
-$0.36 (-1.03%)
Updated
Feb 21 closing price
Net Assets
1.32B
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

ETNHX vs JNGLX

Header iconETNHX vs JNGLX Comparison
Open Charts ETNHX vs JNGLXBanner chart's image
Eventide Healthcare & Life Sciences N
Price$34.51
Change-$0.36 (-1.03%)
VolumeN/A
Net Assets1.32B
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
ETNHX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ETNHX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNHX is a Hold and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. ETNHX (1.32B). JNGLX pays higher dividends than ETNHX: JNGLX (0.12) vs ETNHX (0.00). ETNHX was incepted earlier than JNGLX: ETNHX (12 years) vs JNGLX (26 years). ETNHX is a more actively managed with annual turnover of: 79.00 vs. JNGLX (34.00). ETNHX has a lower initial minimum investment than JNGLX: ETNHX (1000) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. ETNHX (-4.90). JNGLX return over 5 years is better than : 17.54 vs. ETNHX (-12.31).
ETNHXJNGLXETNHX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years26 years-
Gain YTD6.3155.421117%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.32B5B26%
Annual Yield % from dividends0.000.12-
Returns for 1 year-4.90-3.67134%
Returns for 3 years8.2815.9752%
Returns for 5 years-12.3117.54-70%
Returns for 10 years54.3229.25186%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P